Target intelligence / Profile preview

Human coronavirus OC43 3C-like protease (3CLpro)

Target
3CLpro
Molecular classification
Enzyme, Cysteine protease, Chymotrypsin-like protease
01

Overview

The Human coronavirus OC43 3C-like protease (hCoV-OC43 3CLpro), also known as the main protease (Mpro) or non-structural protein 5 (nsp5), is an essential enzyme for the life cycle of the hCoV-OC43 virus [1, 2]. As a cysteine protease, it functions as a homodimer and is responsible for the proteolytic processing of the viral polyproteins pp1a and pp1ab into functional non-structural proteins [1, 8]. This cleavage is a prerequisite for the assembly of the viral replication-transcription complex, making the enzyme indispensable for viral replication [4, 10]. hCoV-OC43 is a major cause of the common cold and can lead to more severe respiratory tract infections in vulnerable populations [13, 14]. Due to its critical role and high conservation among coronaviruses, 3CLpro is a primary target for the development of broad-spectrum antiviral therapeutics [1, 8]. Drugs such as nirmatrelvir and various experimental peptidomimetics interact with the enzyme's active site, often forming covalent bonds with the catalytic cysteine residue to inhibit its activity [2, 8]. Successful inhibition of this protease effectively halts the production of new viral particles, providing a robust mechanism for treating coronavirus infections [4, 11].

Other names
Main proteaseMpro3CL proteaseNon-structural protein 5nsp5C30 endopeptidase
02

Mechanism of action

Inhibition of viral polyprotein cleavage by binding to the active site of the 3C-like protease, thereby preventing the maturation of non-structural proteins and halting viral replication.

03

Biological functions

Viral polyprotein processingViral replicationViral transcription
04

Disease associations

InfectionCommon coldRespiratory tract infection
05

Safety considerations

Drug resistanceOff-target effectsPharmacokinetic challenges
06

Interacting drugs

Nirmatrelvir

10 more in the full profile.

07

Biomarkers

Viral loadCytopathic effect

Beyond the preview

Go deeper on Human coronavirus OC43 3C-like protease (3CLpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human coronavirus OC43 3C-like protease (3CLpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call